MedPath

NAGASAKI UNIVERSITY

🇯🇵Japan
Ownership
-
Established
1949-01-01
Employees
-
Market Cap
-
Website
http://www.nagasaki-u.ac.jp

Clinical Trials

11

Active:0
Completed:6

Trial Phases

3 Phases

Phase 1:1
Phase 4:1
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (66.7%)
Phase 1
1 (16.7%)
Phase 4
1 (16.7%)

Enhancing Health Literacy Through AI-Powered Chatbot

Not Applicable
Not yet recruiting
Conditions
Healthy
First Posted Date
2024-12-05
Last Posted Date
2024-12-05
Lead Sponsor
Nagasaki University
Target Recruit Count
844
Registration Number
NCT06718166
Locations
🇬🇧

London School of Hygiene and Tropical Medicine, London, United Kingdom

Effectiveness of Point-of-care Lung Ultrasound for the Management of Childhood Lower Respiratory Infections

Not Applicable
Not yet recruiting
Conditions
LRTI
Bronchiolitis
Pneumonia
Lower Respiratory Infection
First Posted Date
2023-06-27
Last Posted Date
2023-11-09
Lead Sponsor
Nagasaki University
Target Recruit Count
616
Registration Number
NCT05921526
Locations
🇳🇵

Siddhi Memorial Hospital, Bhaktapur, Bagmati, Nepal

Bone Microstructure by Using HR-pQCT After Esophagectomy

Not yet recruiting
Conditions
Osteoporosis
Sarcopenia
Esophageal Cancer
First Posted Date
2023-04-13
Last Posted Date
2023-04-24
Lead Sponsor
Nagasaki University
Target Recruit Count
118
Registration Number
NCT05812235

Assessing the Surgical Skills of Trainees in Learning the LDG

Not Applicable
Completed
Conditions
Surgical Procedure, Unspecified
Gastrostomy
Assessment, Self
First Posted Date
2018-01-24
Last Posted Date
2021-01-05
Lead Sponsor
Nagasaki University
Target Recruit Count
31
Registration Number
NCT03408795
Locations
🇯🇵

Nagasaki University Hospital, Nagasaki, Japan

Bone Microstructure After Gastrectomy Evaluating by Using HR-pQCT

Conditions
Gastric Cancer
Osteoporosis
Sarcopenia
First Posted Date
2018-01-12
Last Posted Date
2018-01-17
Lead Sponsor
Nagasaki University
Target Recruit Count
42
Registration Number
NCT03398226
Locations
🇯🇵

Nagasaki University Hospital, Nagasaki, Japan

  • Prev
  • 1
  • 2
  • Next

News

CEPI Awards $5 Million to Nagasaki University for Revolutionary 'Nanoball' mRNA Vaccine Platform

CEPI has awarded up to $5 million to Nagasaki University to develop a novel 'nanoball' mRNA vaccine platform that could overcome current storage and delivery limitations of traditional mRNA vaccines.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.